OncLive SOSS (@onclivesoss) 's Twitter Profile
OncLive SOSS

@onclivesoss

Premier oncology summits that focus on the most relevant cancer topics to ultimately improve patient care. #OncLiveIPC

ID: 824013573873668096

linkhttp://www.onclive.com/meetings/soss calendar_today24-01-2017 21:58:40

25,25K Tweet

2,2K Followers

746 Following

OncLive SOSS (@onclivesoss) 's Twitter Profile Photo
OncLive SOSS
@onclivesoss

a year ago

Foluso Bisi Ademuyiwa, MD, MPH, MSCI, of Siteman Cancer Center, discusses the implications of the phase 3 KEYNOTE-522 trial in high-risk, early-stage triple-negative breast cancer. #bcsm ow.ly/xrHB50OTa4q

Foluso Bisi Ademuyiwa, MD, MPH, MSCI, of <a href="/SitemanCenter/">Siteman Cancer Center</a>, discusses the implications of the phase 3 KEYNOTE-522 trial in high-risk, early-stage triple-negative breast cancer. #bcsm ow.ly/xrHB50OTa4q